Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Wizz Air shares jump 9% on higher profit, cash growth and fleet deferral (Investing.com) +++ WIZZ AIR Aktie +9,08%

TERUMO Aktie

 >TERUMO Aktienkurs 
13.2 EUR    -3.7%    (Tradegate)
Ask: 13.2 EUR / 501 Stück
Bid: 13.1 EUR / 383 Stück
Tagesumsatz: 370 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
TERUMO Aktie über LYNX handeln
>TERUMO Performance
1 Woche: -4,9%
1 Monat: -4,2%
3 Monate: -15,0%
6 Monate: -21,4%
1 Jahr: -27,7%
laufendes Jahr: -31,0%
>TERUMO Aktie
Name:  TERUMO CORP.
Land:  Japan
Sektor:  Gesundheit
ISIN/ Wkn:  JP3546800008 / 867003
Symbol/ Ticker:  TUO (Frankfurt)
Kürzel:  FRA:TUO, ETR:TUO, TUO:GR
Index:  Nikkei225
Webseite:  https://www.terumo.co.jp/
Profil:  Terumo Corporation, a leading global medical devic..
>Volltext..
Marktkapitalisierung:  20867.27 Mio. EUR
Unternehmenswert:  20664.14 Mio. EUR
Umsatz:  6227.06 Mio. EUR
EBITDA:  1636.19 Mio. EUR
Nettogewinn:  749.51 Mio. EUR
Gewinn je Aktie:  0.51 EUR
Schulden:  1019.03 Mio. EUR
Liquide Mittel:  1225.65 Mio. EUR
Operativer Cashflow:  1246.33 Mio. EUR
Bargeldquote:  0.75
Umsatzwachstum:  9.27%
Gewinnwachstum:  7.79%
Dividende je Aktie:  0.16 EUR
Dividendenrendite:  1.11%
Dividendenschätzung:  1.19%
Div. Historie:  29.09.25 - 0.085464€
28.03.25 - 0.0740688€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  TERUMO
Letzte Datenerhebung:  13.11.25
>TERUMO Kennzahlen
Aktien/ Unternehmen:
Aktien: 1474.95 Mio. St.
Frei handelbar: 86.91%
Leerverk. Aktien: -
Rückkaufquote: 0.86%
Mitarbeiter: 30689
Umsatz/Mitarb.: 0.19 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 34.64%
Bewertung:
KGV: 27.53
KGV lG: 24.15
KUV: 3.58
KBV: 2.51
PEG-Ratio: 4.42
EV/EBITDA: 12.63
Rentabilität:
Bruttomarge: 54.78%
Gewinnmarge: 12.04%
Operative Marge: 18.03%
Managementeffizenz:
Gesamtkaprendite: 6.81%
Eigenkaprendite: 8.96%
>TERUMO Peer Group

Es sind 52 Aktien bekannt.
 
12.11.25 - 15:54
 Terumo reports 1H results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.11.25 - 08:55
 Terumo Cuts Annual Net Income Outlook On Expenses, Impairment; Ups Revenue Guidance (AFX)
 
TOKYO (dpa-AFX) - Terumo Corporation (TRUMF, 4543.T) on Wednesday revised down its annual net earnings outlook, mainly due to expenses related to acquisition and impairment losses. In addition, th......
12.11.25 - 08:24
 Terumo Corporation Profit Advances In H1 (AFX)
 
TOKYO (dpa-AFX) - Terumo Corporation (TRUMF) revealed earnings for its first half that Increased, from the same period last yearThe company's earnings came in at JPY76.897 billion, or JPY52.12 per......
29.10.25 - 20:06
 Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025 (PR Newswire)
 
Collaboration Highlights Minimally Invasive Neurovascular Stroke Treatment and Expands Public Awareness on Early Recognition and Access to Care DANVILLE, Pa. and ALISO VIEJO, Calif., Oct. 29, 2025 /PRNewswire/ -- In honor of World Stroke Day 2025, Geisinger and Terumo Neuro, a global......
24.10.25 - 14:03
 Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance (PR Newswire)
 
OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs in treating coronary artery disease DualView imaging catheter offers a 150mm maximum pullback length, a 2.6 Fr. imaging profile, 6 Fr. guide......
22.10.25 - 16:43
 The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies (PR Newswire)
 
— Second U.S. site to deploy the Reveos ™ system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center......
30.09.25 - 12:03
 Kenya, Uganda and Côte d′Ivoire Partner with Terumo Blood and Cell Technologies to Build Coordinated National Care Frameworks for Sickle Cell Care (PR Newswire)
 
LAKEWOOD, Colo., Sept. 30, 2025 /PRNewswire/ -- In a landmark move, the Ministries of Health of Kenya and Côte d'Ivoire, together with Uganda's Joint Clinical Research Centre (JCRC) under the stewardship of the Uganda Ministry of Health, have signed three Memoranda of Understanding (MoUs)......
03.09.25 - 09:01
 Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care (PR Newswire)
 
"Bringing Effective Solutions to Life" Through A Dedicated EMEA Initiative Designed to Simplify Collaboration, Showcase A Comprehensive Hemorrhagic Portfolio, And Empower Physicians to Improve Patient Outcomes MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ -- Terumo Neuro, a global leader......
03.09.25 - 09:01
 Terumo Neuro Unveils New SOFIA™ Flow 88 Neurovascular Aspiration Catheter Data from EMEA Demonstrating Strong Performance (PR Newswire)
 
Real-World EMEA Physician Preference Data1 Demonstrates the SOFIA Flow 88 Aspiration Catheter's Trackability, Navigation, and Overall Performance in Stroke Procedures MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly......
28.08.25 - 06:30
 Japan′s Terumo justifies $1.5bn organ transplant deal after share slide (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
25.08.25 - 10:54
 Japan′s Terumo to Buy British Firm for Organ Transplant Biz (Nippon)
 
Tokyo, Aug. 25 (Jiji Press)--Japanese medical equipment maker Terumo Corp. said Monday that it will fully acquire OrganOx Ltd., a British maker of equipment to preserve organs for transplantation, for 1.5 billion dollars. The acquisition will allow Terumo to make a full-fledged entry into the organ transplantation market, which is forecast to grow. Set up in 2008 as a spinoff from the Uni......
25.08.25 - 10:30
 Terumo to buy OrganOx for $1.5bn to enter organ transplant market (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
25.08.25 - 07:57
 Terumo buys OrganOx in $1.5B deal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.08.25 - 03:48
 Terumo Corp. To Acquire OrganOx Limited In $1.5 Bln Deal (AFX)
 
TOKYO (dpa-AFX) - Terumo Corp. (TRUMF) has agreed to acquire all outstanding shares of OrganOx Limited, a company specializing in organ preservation devices. The total transaction value is approxi......
25.08.25 - 02:30
 Terumo to Buy UK Organ Tech Provider OrganOx for $1.5 Billion (Bloomberg)
 
Terumo Corp. has agreed to buy UK-based organ medical tech company OrganOx Ltd. in a deal valued at around $1.5 billion, seeking entry into the organ transplant field....
14.07.25 - 15:03
 Terumo Neuro Unveils New SOFIA™ 88 Catheter Data Demonstrating Strong Performance Compared to Other Super-Bore Catheters (PR Newswire)
 
Real-World U.S. Physician Preference Data1 Demonstrates the SOFIA™ 88 Catheter's Trackability, Atraumatic Design, and Overall Performance in Stroke Procedures NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned......
09.07.25 - 15:03
 Terumo Health Outcomes Announces Distribution Agreement for Caretaker Medical′s VitalStream® Non-Invasive Hemodynamic Monitoring (PR Newswire)
 
– VitalStream wearable delivers real-time, beat-by-beat insights to help clinicians detect cardiovascular changes earlier and respond faster – SOMERSET, N.J., July 9, 2025 /PRNewswire/ -- Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), today announced a......
17.06.25 - 09:06
 MedHub-AI and Terumo partner to market AI-based FFR in Japan (PR Newswire)
 
TEL AVIV, Israel, June 17, 2025 /PRNewswire/ -- MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market.......
02.06.25 - 09:03
 Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter (PR Newswire)
 
Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility PARIS, June 2, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in......
27.05.25 - 19:42
 Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System (PR Newswire)
 
– Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures – SOMERSET, N.J., May 27, 2025 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, is......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Unter jedem Stein schläft ein Skorpion. - Sub omni lapide scorpius dormit. - Macarius Hieromonachus
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!